EFFECTS OF DIETARY POLYUNSATURATED FAT ON HELICOBACTER PYLORI

膳食多不饱和脂肪对幽门螺杆菌的影响

基本信息

  • 批准号:
    6310016
  • 负责人:
  • 金额:
    $ 20.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-12-01 至 2001-02-28
  • 项目状态:
    已结题

项目摘要

Helicobacter pylori (H. pylori) infection is the most common cause of chronic gastritis in man, and it has been implicated as an etiological factor in the development of peptic ulcer disease. More recently, epidemiological studies have demonstrated that H. pylori is an independent risk factor for gastric cancer and that people infected with H. pylori have a 3-6 fold higher risk of developing this condition than non-infected persons. Progression from H. pylori-related superficial gastritis to atrophic gastritis with intestinal metaplasia is felt to be a precursor to gastric cancer development. Investigators have postulated that the natural progression of H. pylori-associated chronic gastritis is to atrophic gastritis, which may be prolonged or shortened by dietary factors. Diets rich in fruits and vegetables and low in starch and salt are associated with a decreased risk of gastric cancer. The presence of antioxidants in these diets has been postulated to be the factors responsible for the decrease in cancer risk. These diets are also high in polyunsaturated fat which, as opposed to saturated ft, has been shown to inhibit bacterial growth. Recent studies have confirmed that polyunsatuated hat will inhibit H. pylori (named as a Class I carcinogen with an estimated attributable risk of 50-60% for gastric cancer by the World Health Organization) growth in vitro. Therefore, agents which inhibit bacterial growth, i.e., polyunsaturated fats are likely to decrease the risk of cancer due to this carcinogen. Investigators for this project postulate that diets high in fruits and vegetables protect gastric cancer because of the bacterial static properties of polyunsaturated fats. Since antioxidants such as vitamin E are present in oils rich in polyunsaturated fat, they feel that they serve mainly as a marker for ingestion of these fats, and are not the primary agents protecting against gastric cancer. This grant proposes to document in a cross-sectional study, the indirect correlation between polyunsaturated fat ingestion and gastric bacterial load. In vitro studies will be performed to elucidate the extent to which polynsaturated fat will not only inhibit growth, but also inhibit cytotoxicity induced by adherence of this bacterium to human gastric epithelial cells. Confirming this hypothesis would be very important to areas of the world which have a high incidence of gastric cancer, since these areas have both a high incidence of H. pylori and a high rate of re-infection with this organism after successful antibiotic treatment. Knowledge that dietary intake rich in polyunsaturated fat will reduce gastric cancer risk is likely to be a cost-effective way of preventing this disease, since there is a vaccine available and antibiotic therapy is not practical in certain countries.
幽门螺杆菌(H.幽门螺杆菌)感染是人类慢性胃炎的最常见原因,并且它已被认为是消化性溃疡疾病发展的致病因素。 近年来,流行病学研究表明,H。pylori是胃癌的独立危险因素,H.幽门螺杆菌感染者比未感染者发生这种病症的风险高3-6倍。从H.幽门相关性浅表性胃炎到伴有肠上皮化生的萎缩性胃炎被认为是胃癌发展的前兆。 研究者推测,H.幽门相关性慢性胃炎是萎缩性胃炎,可因饮食因素而延长或缩短。 富含水果和蔬菜以及低淀粉和盐的饮食与降低胃癌风险有关。 这些饮食中抗氧化剂的存在被认为是降低癌症风险的因素。这些饮食也富含多不饱和脂肪,与饱和脂肪酸相反,多不饱和脂肪酸已被证明能抑制细菌生长。 最近的研究证实多不饱和帽能抑制H。幽门螺杆菌(世界卫生组织将其命名为I类致癌物,估计胃癌的归因风险为50-60%)体外生长。 因此,抑制细菌生长的药物,即,多不饱和脂肪可能会降低这种致癌物质导致的癌症风险。 该项目的研究人员假设,多水果和蔬菜的饮食可以保护胃癌,因为多不饱和脂肪的细菌静态特性。由于维生素E等抗氧化剂存在于富含多不饱和脂肪的油中,他们认为它们主要作为摄入这些脂肪的标志物,而不是预防胃癌的主要药物。 这项资助计划在一项横断面研究中记录多不饱和脂肪摄入与胃细菌负荷之间的间接相关性。 将进行体外研究,以阐明多不饱和脂肪不仅抑制生长,而且抑制该细菌粘附于人胃上皮细胞诱导的细胞毒性的程度。 证实这一假说对于世界上胃癌高发地区是非常重要的,因为这些地区既有高的H。幽门螺杆菌和高的再感染率与此有机体后,成功的抗生素治疗。从饮食中摄入富含多不饱和脂肪的食物会降低胃癌风险,这一知识可能是预防胃癌的一种具有成本效益的方法,因为在某些国家,已有疫苗可供使用,而抗生素治疗并不实用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DUANE T. SMOOT其他文献

DUANE T. SMOOT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DUANE T. SMOOT', 18)}}的其他基金

MAAAI
玛艾
  • 批准号:
    7951448
  • 财政年份:
    2009
  • 资助金额:
    $ 20.62万
  • 项目类别:
Differential Transcription Factor Activation by H. pylor
幽门螺杆菌激活差异转录因子
  • 批准号:
    6733126
  • 财政年份:
    2003
  • 资助金额:
    $ 20.62万
  • 项目类别:
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
霍华德大学癌症中心/约翰霍普金斯癌症中心合作伙伴关系
  • 批准号:
    7498420
  • 财政年份:
    2001
  • 资助金额:
    $ 20.62万
  • 项目类别:
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
霍华德大学癌症中心/约翰霍普金斯癌症中心合作伙伴关系
  • 批准号:
    8144502
  • 财政年份:
    2001
  • 资助金额:
    $ 20.62万
  • 项目类别:
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
霍华德大学癌症中心/约翰霍普金斯癌症中心合作伙伴关系
  • 批准号:
    7687007
  • 财政年份:
    2001
  • 资助金额:
    $ 20.62万
  • 项目类别:
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
霍华德大学癌症中心/约翰霍普金斯癌症中心合作伙伴关系
  • 批准号:
    8150102
  • 财政年份:
    2001
  • 资助金额:
    $ 20.62万
  • 项目类别:
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
霍华德大学癌症中心/约翰霍普金斯癌症中心合作伙伴关系
  • 批准号:
    7931026
  • 财政年份:
    2001
  • 资助金额:
    $ 20.62万
  • 项目类别:
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI
幽门螺杆菌激活差异转录因子
  • 批准号:
    6024234
  • 财政年份:
    1999
  • 资助金额:
    $ 20.62万
  • 项目类别:
DIFFERENTIAL TRANSCRIPTION FACTOR ACTIVATION BY H PYLORI
幽门螺杆菌激活差异转录因子
  • 批准号:
    6024392
  • 财政年份:
    1998
  • 资助金额:
    $ 20.62万
  • 项目类别:
EFFECTS OF DIETARY POLYUNSATURATED FAT ON HELICOBACTER PYLORI
膳食多不饱和脂肪对幽门螺杆菌的影响
  • 批准号:
    6265913
  • 财政年份:
    1998
  • 资助金额:
    $ 20.62万
  • 项目类别:

相似海外基金

Urinary Phthalate Biomarker Concentrations and Breast and Prostate Cancer Risk in a National Cohort of Adults in Canada
加拿大全国成人队列中尿液邻苯二甲酸盐生物标志物浓度与乳腺癌和前列腺癌风险
  • 批准号:
    494953
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Operating Grants
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
  • 批准号:
    10912190
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
  • 批准号:
    10805177
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
  • 批准号:
    10719777
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
开发患者特异性癌症风险和早期肿瘤发生的诊断方法
  • 批准号:
    478999
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Operating Grants
Environmental Metal Exposures and Breast Cancer Risk: A Prospective Study of Nationally Representative Canadian Data
环境金属暴露与乳腺癌风险:加拿大全国代表性数据的前瞻性研究
  • 批准号:
    495159
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
  • 批准号:
    10650054
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
影响减肥手术后结直肠癌风险的肠道微生物相关机制
  • 批准号:
    10733566
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?
肥胖、身体脂肪分布和乳腺癌风险:内脏脂肪是绝经后的罪魁祸首吗?
  • 批准号:
    10586626
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
Optimization of a personalized skin cancer risk intervention for at-risk young adults
针对高危年轻人的个性化皮肤癌风险干预措施的优化
  • 批准号:
    10582944
  • 财政年份:
    2023
  • 资助金额:
    $ 20.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了